A detailed history of Miracle Mile Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Miracle Mile Advisors, LLC holds 5,840 shares of AMGN stock, worth $1.64 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
5,840
Previous 5,168 13.0%
Holding current value
$1.64 Million
Previous $1.61 Million 16.54%
% of portfolio
0.05%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$309.38 - $337.38 $207,903 - $226,719
672 Added 13.0%
5,840 $1.88 Million
Q2 2024

Jul 18, 2024

BUY
$262.75 - $319.31 $66,738 - $81,104
254 Added 5.17%
5,168 $1.61 Million
Q1 2024

Apr 18, 2024

BUY
$268.87 - $324.56 $81,467 - $98,341
303 Added 6.57%
4,914 $1.4 Million
Q4 2023

Jan 22, 2024

BUY
$255.7 - $288.46 $323,204 - $364,613
1,264 Added 37.77%
4,611 $1.33 Million
Q3 2023

Oct 25, 2023

SELL
$218.65 - $271.46 $1,530 - $1,900
-7 Reduced 0.21%
3,347 $899,000
Q2 2023

Jul 13, 2023

BUY
$214.27 - $253.37 $58,924 - $69,676
275 Added 8.93%
3,354 $744,000
Q1 2023

Apr 20, 2023

SELL
$225.79 - $275.2 $21,450 - $26,144
-95 Reduced 2.99%
3,079 $744,000
Q4 2022

Jan 20, 2023

BUY
$229.03 - $291.01 $18,322 - $23,280
80 Added 2.59%
3,174 $0
Q3 2022

Oct 24, 2022

SELL
$224.46 - $253.15 $8,080 - $9,113
-36 Reduced 1.15%
3,094 $697,000
Q2 2022

Jul 15, 2022

BUY
$230.71 - $256.74 $465,111 - $517,587
2,016 Added 180.97%
3,130 $761,000
Q1 2022

Apr 25, 2022

SELL
$219.27 - $242.57 $23,900 - $26,440
-109 Reduced 8.91%
1,114 $270,000
Q4 2021

Jan 18, 2022

SELL
$198.88 - $227.6 $376,678 - $431,074
-1,894 Reduced 60.76%
1,223 $275,000
Q3 2021

Nov 01, 2021

BUY
$212.27 - $248.7 $433,030 - $507,348
2,040 Added 189.42%
3,117 $663,000
Q2 2021

Jul 28, 2021

BUY
$233.58 - $259.14 $9,576 - $10,624
41 Added 3.96%
1,077 $262,000
Q1 2021

Apr 29, 2021

SELL
$221.91 - $258.6 $474,887 - $553,404
-2,140 Reduced 67.38%
1,036 $258,000
Q4 2020

Jan 19, 2021

BUY
$216.38 - $257.67 $504,598 - $600,886
2,332 Added 276.3%
3,176 $730,000
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $198,044 - $220,241
844 New
844 $215,000
Q2 2020

Aug 06, 2020

SELL
$197.81 - $242.74 $206,711 - $253,663
-1,045 Closed
0 $0
Q1 2020

May 11, 2020

SELL
$182.24 - $241.7 $148,707 - $197,227
-816 Reduced 43.85%
1,045 $212,000
Q4 2019

Feb 10, 2020

BUY
$189.21 - $243.2 $116,174 - $149,324
614 Added 49.24%
1,861 $449,000
Q3 2019

Nov 06, 2019

SELL
$174.11 - $208.62 $135,979 - $162,932
-781 Reduced 38.51%
1,247 $241,000
Q2 2019

Aug 07, 2019

BUY
$166.7 - $195.41 $4,667 - $5,471
28 Added 1.4%
2,028 $374,000
Q1 2019

May 07, 2019

BUY
$180.87 - $203.88 $1,446 - $1,631
8 Added 0.4%
2,000 $380,000
Q4 2018

Jan 22, 2019

BUY
$178.4 - $208.25 $8,920 - $10,412
50 Added 2.57%
1,992 $388,000
Q2 2018

Aug 08, 2018

BUY
$166.05 - $186.51 $20,756 - $23,313
125 Added 6.88%
1,942 $358,000
Q1 2018

May 02, 2018

SELL
$169.43 - $198.0 $3,388 - $3,960
-20 Reduced 1.09%
1,817 $310,000
Q4 2017

Feb 07, 2018

SELL
$168.79 - $188.59 $16,035 - $17,916
-95 Reduced 4.92%
1,837 $319,000
Q3 2017

Oct 31, 2017

BUY
$167.29 - $191.0 $323,204 - $369,012
1,932
1,932 $360,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Miracle Mile Advisors, LLC Portfolio

Follow Miracle Mile Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Miracle Mile Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Miracle Mile Advisors, LLC with notifications on news.